NCT04319237 2026-03-02
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
H. Lee Moffitt Cancer Center and Research Institute
Completed
Clinical Trials
12 trialsNCT05510596 2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA Completed
NCT03508765 2024-03-08
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01854554 2024-01-02
Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT04075370 2023-01-20
Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer
Duke University
Completed
NCT00550134 2021-12-30
Cognitive Changes Associated With Breast Cancer Treatment
Memorial Sloan Kettering Cancer Center
Completed
NCT02903784 2020-09-02
BNL
University Hospital, Montpellier
Phase NA Completed
NCT04118426 2019-10-10
WP-12-pre
University of Aarhus
Completed
NCT02023346 2018-11-01
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
Memorial Sloan Kettering Cancer Center
Completed
NCT01988675 2018-06-06
MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier
University of Michigan Rogel Cancer Center
Completed
NCT01851135 2016-07-06
NF1-QDV
Nantes University Hospital
Phase NA Completed
NCT00188331 2016-03-22
Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy
University Health Network, Toronto
Completed